Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Proposals to change corporate tax rates and related laws Advocate on drug pricing proposals, expanding access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Engage on pharmaceutical policy as it relates to payments under the 340B program. Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments for COVID-19 (2019 Novel Coronavirus), including: manufacturing, clinical trials, reimbursement and coverage of Veklury (remdesivir). 

H.R.1319 - American Rescue Plan Act of 2021 Funding for Hepatitis C, HIV, and public health activities via appropriations. 

H.R.1319 - American Rescue Plan Act of 2021 Education related to antivirals and oncology products. Advocate on drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and Value-Based Purchasing arrangements. International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries.
CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code HCR - Health Issues BUD - Budget/Appropriations VET - Veterans MMM - Medicare/Medicaid TRD - Trade (domestic/foreign)
134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404, US
DAVID PULLIAM CHARLES M. CLAPTON JENNIFER NIETO CAREY CHARLES M. CLAPTON DAVID PULLIAM DAVID PULLIAM CHARLES M. CLAPTON MICHAEL D BOYD ANNA GRIFFIN JENNIFER NIETO CAREY TERESA BILL DAVID PULLIAM CHARLES M. CLAPTON JENNIFER NIETO CAREY TERESA BILL DAVID PULLIAM CHARLES M. CLAPTON DAVID PULLIAM CHARLES M. CLAPTON MICHAEL D BOYD ANNA GRIFFIN JENNIFER NIETO CAREY TERESA BILL DAVID PULLIAM CHARLES M. CLAPTON